Back to Rounds
Series D Round
Funding Details
SpyGlass Pharma is a biotechnology startup focused on developing innovative drug delivery solutions for chronic ophthalmic diseases. Their flagship product is the world's first intraocular lens (IOL)-mounted, controlled release drug delivery platform, designed to provide long-term therapy for glaucoma patients. The recent funding will be utilized to advance their drug delivery platform and expand their clinical trials.
Confidence Score
Participating Investors
No investors recorded for this funding round.
Related Tweets
No tweets found for this funding round.